Clinical Trials on Uveal Neoplasms

Total 108139 results

Aura Biosciences

Recruiting

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma (CoMpass)

Ocular Melanoma | Uveal Melanoma | Choroidal Melanoma | Indeterminate Lesions

United States, Australia, United Kingdom
Alimera Sciences
CBCC Global Research

Recruiting

Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis

Uveitis, Posterior

United States
The Cleveland Clinic

Recruiting

Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography (ATAC)

Uveitis

United States
The Cleveland Clinic
Santen Inc.

Active, not recruiting

Imaging Quantification of Inflammation (IQI) (IQI)

Uveitis

United States
AbbVie

Completed

Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients

Non-infectious Intermediate, Posterior and Panuveitis

Korea, Republic of
Assiut University

Unknown

Treatment Outcome of Uveitis in Autoimmune Diseases

Autoimmune Uveitis
Vanderbilt University
Pfizer

Terminated

Intravitreal Celecoxib for Chronic Uveitis (Celecoxib)

Inflammation
Hospital Hietzing
Medical University of Vienna

Completed

Quality of Life in Juvenile Patients With Uveitis

Uveitis

Austria
National Eye Institute (NEI)

Completed

Biomarkers in Ocular Inflammation and Uveitis

Uveitis | Ocular Inflammation

United States
National Eye Institute (NEI)

Completed

Analysis of Eye Tissue

Inflammation | Uveitis | Eye Disease

United States
National Eye Institute (NEI)

Completed

Cyclosporin Implant to Treat Uveitis

Inflammation | Uveitis | Eye Disease

United States
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Completed

Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery

Metastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Unresectable Melanoma | Mucosal Melanoma | Stage IV Uveal Melanoma AJCC v7

United States
Iconic Therapeutics, Inc.

Terminated

Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) (DECO)

Choroidal Neovascularization | Wet Macular Degeneration

United States
Novartis

Completed

Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis

Panuveitis | Uveitis | Posterior Uveitis

United States
National Eye Institute (NEI)

Completed

Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients

Cataracts

United States
Iconic Therapeutics, Inc.

Completed

Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (EMERGE)

Age-related Macular Degeneration | Choroidal Neovascularization

United States
Retina Research Institute, LLC

Completed

Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome

Choroidal Neovascularization | Presumed Ocular Histoplasmosis

United States
Russian Academy of Medical Sciences

Recruiting

Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519) (ICIPRESIST19)

Melanoma | Hodgkin Lymphoma | Uveal Melanoma | Squamous Cell Lung Cancer

Russian Federation
Eyegate Pharmaceuticals, Inc.

Completed

Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis (EGP-437-006)

Anterior Uveitis

United States
Eyegate Pharmaceuticals, Inc.

Completed

Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis

Anterior Uveitis

United States
National Taiwan University Hospital

Unknown

Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis

Anterior Uveitis

Taiwan
Allergan

Terminated

A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis

Anterior Uveitis

United States
Priovant Therapeutics, Inc.

Not yet recruiting

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis (CLARITY) (CLARITY)

Uveitis | Uveitis, Posterior | Uveitis, Intermediate
Mansoura University

Completed

Stepped Surgery in Uveitic Cataract: A Novel Approach to a Quiet Eye

Outcome of Stepped Cataract Surgery in Uveitis

Egypt
Santen Inc.

Completed

A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program (SPRING)

Non-Infectious Uveitis of the Posterior Segment of the Eye

United States, France, Turkey, Italy, Austria, India
STZ eyetrial
Novartis Pharmaceuticals; University Hospital Tuebingen

Completed

Myfortic for the Treatment of Non-infectious Intermediate Uveitis (MYCUV-IIT02)

Uveitis, Intermediate

Germany
Santen Inc.
MacuSight, Inc.

Terminated

Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration

Age-related Macular Degeneration | Choroidal Neovascularization

United States
Ottawa Hospital Research Institute

Recruiting

Ozurdex Monotherapy Trial (OM)

Panuveitis | Uveitis, Posterior | Uveitis, Intermediate

Canada
Eli Lilly and Company

Active, not recruiting

A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Uveitis

France, Spain, Germany, United Kingdom, Italy
AbbVie

Active, not recruiting

A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis

Non-infectious Intermediate Posterior- or Pan-uveitis

China
Moorfields Eye Hospital NHS Foundation Trust

Completed

Childhood Uveitis Initial Management and One-year Outcomes

Uveitis

United Kingdom
The Eye Hospital of Wenzhou Medical University

Completed

Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy

Central Serous Choroidopathy

China
Can-Fite BioPharma

Withdrawn

Safety &Efficacy of CF101 to Subjects With Uveitis

Uveitis, Posterior | Uveitis, Intermediate

Israel
Novartis Pharmaceuticals

Withdrawn

Study of FTY720 in Patients With Uveitis

Acute Noninfectious Posterior, Intermediate, or Pan Uveitis
Texas Retina Associates
Alcon Research

Completed

Prophylactic Anecortave Acetate in Patients With a Retisert Implant

Glaucoma | Uveitis, Posterior

United States
Novartis

Completed

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen (REPAIR)

Choroidal Neovascularisation

United Kingdom
Benha University

Completed

Dexamethasone Intravitreal Implant (Ozurdex®) for Recurrent Vogt-Koyanagi-Harada (VKH) Disease Posterior Uveitis

Posterior Uveitis

United Arab Emirates
Massachusetts Eye and Ear Infirmary
BioElectronics Corporation

Completed

PEMF: an Adjunct Therapy for Anterior Uveitis (PEMF)

Anterior Uveitis | Iritis

United States
Nisha Acharya
Children's Hospital of Philadelphia; University of Miami; National Eye Institute... and other collaborators

Active, not recruiting

Adalimumab in JIA-associated Uveitis Stopping Trial (ADJUST)

Uveitis | JIA

United States, Australia, United Kingdom
National Eye Institute (NEI)

Completed

Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti

Anterior Uveitis

United States
Perspective Therapeutics

Recruiting

MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma

Metastatic Melanoma | Melanoma (Skin) | Mucosal Melanoma | Melanoma Stage IV | Melanoma Stage III | Melanoma, Uveal

United States
Hoffmann-La Roche

Completed

A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) (AVENUE)

Choroidal Neovascularization

United States
Genentech, Inc.

Completed

A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Age-related Macular Degeneration | Choroidal Neovascularization
Ophthalmic Consultants of Boston
Genentech, Inc.

Completed

Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.

Choroidal Neovascularization
University of California, San Francisco
Khon Kaen University; King Chulalongkorn Memorial Hospital; Huang Pacific Foundation

Recruiting

Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes (STACCATO)

Cytomegalovirus Anterior Uveitis

Thailand, United States
Moorfields Eye Hospital NHS Foundation Trust

Completed

Advanced OCT and Adaptive Optics Imaging in Retinal Disease (The ACAD Study) (ACAD)

Retinal Diseases | Vitreous Diseases | Choroidal Diseases

United Kingdom
Aristotle University Of Thessaloniki

Completed

Early Diagnosis in Glaucoma With GDxVcc

Exfoliation Syndrome

Greece
Shahid Beheshti University of Medical Sciences

Unknown

To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis

Chorioretinitis

Iran, Islamic Republic of
National Cancer Institute (NCI)

Completed

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Intraocular Melanoma | Recurrent Melanoma | Stage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Extraocular Extension Melanoma | Acral Lentiginous Malignant Melanoma | Lentigo Maligna Malignant Melanoma | Superficial... and other conditions

Canada
University of Southern California
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

Recurrent Melanoma | Stage IV Melanoma | Mucosal Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma | Stage IIIA Melanoma | Stage... and other conditions

United States

Clinical Trials on Uveal Neoplasms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations